Direct-Acting Antivirals and Risk of Hepatitis C Extrahepatic Manifestations

This cohort study examines successful direct-acting antiviral treatment and the risk of extrahepatic manifestations among individuals with chronic hepatitis C virus infections from 1990 to 2021.



Source link